Log in | Register

Search Results

Results 1 to 10 of 107 for "De escalation"

Restrict your results to one of the following articles types (number of results in parentheses):

Restrict your results to those published in the following timeframe (number of results in parentheses):

  1. De-escalation of empirical therapy is associated with lower mortality in patients with severe sepsis and septic shock

    J. Garnacho-Montero, A. Gutiérrez-Pizarraya, A. Escoresca-Ortega, Y. Corcia-Palomo, Esperanza Fernández-Delgado, I. Herrera-Melero, C. Ortiz-Leyba, J. A. Márquez-Vácaro
    Volume 40, Number 1 / January, 2014
    Original Article

  2. De-escalation of antimicrobial treatment in neutropenic patients with severe sepsis: results from an observational study

    Djamel Mokart, Géraldine Slehofer, Jérôme Lambert, Antoine Sannini, Laurent Chow-Chine, Jean-Paul Brun, Pierre Berger, Ségolène Duran, Marion Faucher, Jean-Louis Blache, Colombe Saillard, Norbert Vey, Marc Leone
    Volume 40, Number 1 / January, 2014
    Original Article

  3. Impact of de-escalation of beta-lactam antibiotics on the emergence of antibiotic resistance in ICU patients: a retrospective observational study

    Liesbet De Bus, Wouter Denys, Julie Catteeuw, Bram Gadeyne, Karel Vermeulen, Jerina Boelens, Geert Claeys, Jan J. De Waele, Johan Decruyenaere, Pieter O. Depuydt
    Volume 42, Number 6 / June, 2016
    Original

  4. De-escalation therapy rates are significantly higher by bronchoalveolar lavage than by tracheal aspirate

    Elpis Giantsou, Nikolaos Liratzopoulos, Eleni Efraimidou, Maria Panopoulou, Eleonora Alepopoulou, Sofia Kartali-Ktenidou, Konstantinos Manolas
    Volume 33, Number 9 / September, 2007
    Original

  5. De-escalation versus continuation of empirical antimicrobial treatment in severe sepsis: a multicenter non-blinded randomized noninferiority trial

    Marc Leone, Carole Bechis, Karine Baumstarck, Jean-Yves Lefrant, Jacques Albanèse, Samir Jaber, Alain Lepape, Jean-Michel Constantin, Laurent Papazian, Nicolas Bruder, Bernard Allaouchiche, Karine Bézulier, François Antonini, Julien Textoris, Claude Martin
    Volume 40, Number 10 / October, 2014
    Seven-Day Profile Publication

  6. Antifungal de-escalation was not associated with adverse outcome in critically ill patients treated for invasive candidiasis: post hoc analyses of the AmarCAND2 study data

    Sébastien Bailly, Olivier Leroy, Philippe Montravers, Jean-Michel Constantin, Hervé Dupont, Didier Guillemot, Olivier Lortholary, Jean-Paul Mira, Pierre-François Perrigault, Jean-Pierre Gangneux, Elie Azoulay, Jean-François Timsit
    Volume 41, Number 11 / November, 2015
    Original

  7. Impact of de-escalation on ICU patients’ prognosis

    Jan J. De Waele, Matteo Bassetti, Ignacio Martin-Loeches
    Volume 40, Number 10 / October, 2014
    Editorial

  8. The case for de-escalation in antimicrobial therapy: time to change our strategy in the management of septic shock?

    Matteo Bassetti, José-Artur Paiva, Robert G. Masterton
    Volume 40, Number 2 / February, 2014
    Editorial

  9. What can be expected from antimicrobial de-escalation in the critically ill?

    Marin H. Kollef
    Volume 40, Number 1 / January, 2014
    What’s New in Intensive Care Medicine

  10. Antimicrobial de-escalation in septic cancer patients: is it safe to back down?Open access

    Alla Paskovaty, Stephen M. Pastores, Zivile Gedrimaite, Natalie Kostelecky, Elyn R. Riedel, Susan K. Seo
    Volume 41, Number 11 / November, 2015
    Letter

Sign In

Connect with ICM

Top 5 Articles Editors Picks Supplement